Reckitt Benckiser Group (LON:RKT) Hits New 12-Month Low at $1,747.00

Reckitt Benckiser Group plc (LON:RKT)’s stock price hit a new 52-week low during mid-day trading on Thursday . The stock traded as low as GBX 1,747 ($21.75) and last traded at GBX 4,137 ($51.50), with a volume of 4760313 shares changing hands. The stock had previously closed at GBX 4,110 ($51.16).

Analyst Upgrades and Downgrades

Separately, HSBC reaffirmed a “hold” rating on shares of Reckitt Benckiser Group in a research report on Thursday.

Reckitt Benckiser Group Stock Up 0.7 %

The stock has a fifty day moving average of GBX 4,863.91 and a 200 day moving average of GBX 5,325.61. The firm has a market capitalization of £29.52 billion, a P/E ratio of 1,835.68, a price-to-earnings-growth ratio of 3.76 and a beta of 0.07. The company has a debt-to-equity ratio of 100.80, a current ratio of 0.64 and a quick ratio of 0.46.

Reckitt Benckiser Group Increases Dividend

The firm also recently declared a dividend, which will be paid on Friday, May 24th. Investors of record on Thursday, April 11th will be issued a dividend of GBX 115.90 ($1.44) per share. This is a positive change from Reckitt Benckiser Group’s previous dividend of $76.60. This represents a yield of 1.99%. The ex-dividend date is Thursday, April 11th. Reckitt Benckiser Group’s dividend payout ratio (DPR) is 8,502.20%.

About Reckitt Benckiser Group

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; vaginal care routine products; sore throat medications; and hair removal products under the Clearasil, Dettol, Durex, Gaviscon, Nurofen, Mucinex, Queen V, Strepsils, and Veet brands.